In need of something better than sleep

The Lancet

Volumn 381, Issue 9866, 2013, Pages 598-

  Kim, Han Joon ^a   Jeon, Beom S ^a,c   Yang, Hui Jun ^a   Cho, Joong Yang ^b  

^a Seoul National University Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BACLOFEN; CLONAZEPAM; DIAZEPAM; GLUCOSE; LEVODOPA; PRAMIPEXOLE; TIZANIDINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASEPTIC MENINGITIS; BRADYKINESIA; BRAIN ATROPHY; CASE REPORT; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CONSCIOUSNESS DISORDER; CONSERVATIVE TREATMENT; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG UPTAKE; ENCEPHALITIS; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; LYMPHOCYTE; MESENCEPHALON; MOTOR PERFORMANCE; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SLEEP; SUBSTANTIA NIGRA;

EID: 84873649692     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61892-3     Document Type: Article

References (4)

1. Savant CS, Singhal B, Jankovic J, Khan M, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord 2003; 18: 213-16.
2. V ilensky JA, Gilman S, McCall S. Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic Parkinsonism? Mov Disord 2010; 25: 1124-30.
3. Ghaemi M, Rudolf J, Schmülling S, Bamborschke S, Heiss WD. FDG- and dopa-PET in postencephalitic parkinsonism. J Neural Transm 2000; 107: 1289-95.
4. Ca lne D, Stern G, Laurence D, Sharkey J, Armitage P. L-dopa in postencephalitic parkinsonism. Lancet 1969; 293: 744-47.